BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPTP301S mouse model of tauopathy

Autor: Perez-Garcia, Georgina, Bicak, Mesude, Haure-Mirande, Jean-Vianney, Perez, Gissel M., Otero-Pagan, Alena, Gama Sosa, Miguel A., De Gasperi, Rita, Sano, Mary, Barlow, Carrolee, Gage, Fred H., Readhead, Benjamin, Ehrlich, Michelle E., Gandy, Sam, Elder, Gregory A.
Zdroj: In Neuroscience Letters 16 February 2023 797
Databáze: ScienceDirect